Search in:

OncoTargets and Therapy Volume 10, 2017 - Issue

Submit an article Journal homepage

Open access

Views

CrossRef citations to date

Altmetric

Original Research

The effect of CYP2D6 10* polymorphism on adjuvant tamoxifen in Asian breast cancer patients: a meta-analysis

Junjun Lu1 Department of Tumor, Shanghai Municipal Hospital of Traditional Chinese Medicine

He Li2 Department of Traditional Chinese Medicine, Shanghai Jiao Tong University Medical School Affiliated Ruijin Hospital

Peng Guo1 Department of Tumor, Shanghai Municipal Hospital of Traditional Chinese Medicine

Rui Shen3 Department of Function, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai

Yingbin Luo1 Department of Tumor, Shanghai Municipal Hospital of Traditional Chinese Medicine

Qiao Ge4 Department of Tumor, Ninghai Hospital of Traditional Chinese Medicine, Ningbo, Zhejiang, China

Wenfei Shi1 Department of Tumor, Shanghai Municipal Hospital of Traditional Chinese Medicine

Yan Li1 Department of Tumor, Shanghai Municipal Hospital of Traditional Chinese MedicineCorrespondence[email protected] [email protected]

Weikang Zhu1 Department of Tumor, Shanghai Municipal Hospital of Traditional Chinese MedicineCorrespondence[email protected] [email protected]

show all

Pages 5429-5437 | Published online: 13 Nov 2017

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (17)

Le Guo, Wenjie Zhang, Wenting Meng, Weiwei Zhao, Jie Hao, Xiuxia Hu & Tianbo Jin. (2023) Very important pharmacogenes polymorphism landscape and potential clinical relevance in the Chinese Mongolian. Gene 850, pages 146960.
Crossref

Murat Dzhaubermezov, Natalya Ekomasova, Rustam Mustafin, Lilia Gabidullina, Yuliya Galimova, Alfiya Nurgalieva, Yana Valova, Darya Prokofyeva & Elza Khusnutdinova. (2022) Genetic Polymorphisms of Cytochromes P450 in Finno-Permic Populations of Russia. Genes 13:12, pages 2353.
Crossref

Miguel Trujillo-Martínez, Liliana Gómez-Flores-Ramos, Luisa María Sánchez-Zamorano, Nancy Reynoso-Noverón, Lizbeth Grimaldo, Cidronio Albavera-Hernández & Lourdes Flores-Luna. (2022) Farmacogenética en el cáncer de mama: implicaciones de los genes del citocromo p450 en la supervivencia libre de la enfermedad en las mujeres jóvenes. Revista de Senología y Patología Mamaria 35:4, pages 269-284.
Crossref

Chuang Cui, Chen-Huan Ding, Fang-Fang Liu, Jing-Rong Lu, Shi-Yun Zheng, Hou-Wen Lin, Wei-Kang Zhu, Fan Yang & He Li. (2022) Marine-Derived Stichloroside C2 Inhibits Epithelial–Mesenchymal Transition and Induces Apoptosis through the Mitogen-Activated Protein Kinase Signalling Pathway in Triple-Negative Breast Cancer Cells. Journal of Oncology 2022, pages 1-13.
Crossref

Ramazan Teimouri Yansari, Mitra Mirzarezaee, Mehdi Sadeghi & Babak Nadjar Araabi. (2022) A new survival analysis model in adjuvant Tamoxifen-treated breast cancer patients using manifold-based semi-supervised learning. Journal of Computational Science 61, pages 101645.
Crossref

Thomas P Ahern, Richard F MacLehose, Laura Haines, Deirdre P Cronin-Fenton, Per Damkier, Lindsay J Collin & Timothy L Lash. (2021) Improving the transparency of meta-analyses with interactive web applications. BMJ Evidence-Based Medicine 26:6, pages 327-332.
Crossref

Yen-Shen Lu, Winnie Yeo, Yoon-Sim Yap, Yeon Hee Park, Kenji Tamura, Huiping Li & Rebecca Cheng. (2021) An Overview of the Treatment Efficacy and Side Effect Profile of Pharmacological Therapies in Asian Patients with Breast Cancer. Targeted Oncology 16:6, pages 701-741.
Crossref

Camille Robin, Benjamin Hennart, Franck Broly, Philippine Gruchala, Geoffroy Robin & Sophie Catteau-Jonard. (2021) Could Cytochrome P450 2D6, 3A4 and 3A5 Polymorphisms Explain the Variability in Clinical Response to Clomiphene Citrate of Anovulatory PCOS Women?. Frontiers in Endocrinology 12.
Crossref

Anna Mueller-Schoell, Robin Michelet, Lena Klopp-Schulze, Madelé van Dyk, Thomas E. Mürdter, Matthias Schwab, Markus Joerger, Wilhelm Huisinga, Gerd Mikus & Charlotte Kloft. (2021) Computational Treatment Simulations to Assess the Need for Personalized Tamoxifen Dosing in Breast Cancer Patients of Different Biogeographical Groups. Cancers 13:10, pages 2432.
Crossref

Ezohra Elouilamine, Soumaya El Akil, Fatima Zahra Aznag & El Hassan Izaabel. (2020) CYP2D6 gene polymorphisms and breast cancer risk in Moroccan population: A case-control study. Gene Reports 20, pages 100768.
Crossref

Carmen W. H. Chan, Bernard M. H. Law, Winnie K. W. So, Ka Ming Chow & Mary M. Y. Waye. (2020) Pharmacogenomics of breast cancer: highlighting CYP2D6 and tamoxifen. Journal of Cancer Research and Clinical Oncology 146:6, pages 1395-1404.
Crossref

Xiaoxia Wei, Jiaqin Cai, Jie Zhuang, Bin Zheng, Yuxia Sui, Guifeng Zhang, Ying Lin & Hong Sun. (2020) CYP2D6*10 pharmacogenetic-guided SERM could be a cost-effective strategy in Chinese patients with hormone receptor-positive breast cancer . Pharmacogenomics 21:1, pages 43-53.
Crossref

Xiaoxia Wei, Hong Sun, Jie Zhuang, Xiuhua Weng, Bin Zheng, Qiwang Lin, Guifeng Zhang & Jiaqin Cai. (2019) Cost-effectiveness Analysis of CYP2D6*10 Pharmacogenetic Testing to Guide the Adjuvant Endocrine Therapy for Postmenopausal Women with Estrogen Receptor Positive Early Breast Cancer in China. Clinical Drug Investigation 40:1, pages 25-32.
Crossref

Zhaoqian Liu, Chenxue Mao, Xiangping Li & Jiye Yin. 2020. Pharmacogenomics in Precision Medicine. Pharmacogenomics in Precision Medicine 39 54 .

Yenny, Sonar S. Panigoro, Denni J. Purwanto, Adi Hidayat, Melva Louisa, Rizka Andalusia & Rianto Setiabudy. (2019) Association of CYP2D6*10 (c. 100 C>T) Genotype with Z-END Concentration in Patients with Breast Cancer Receiving Tamoxifen Therapy in Indonesian Population. Endocrine, Metabolic & Immune Disorders - Drug Targets 19:8, pages 1198-1206.
Crossref

Yu Bai, Hai-wei Wu & Yan-hua Zhang. (2018) Effects of CYP2D6*10 polymorphism on tamoxifen pharmacokinetics in patients with breast cancer in Asia: a meta-analysis. Cancer Chemotherapy and Pharmacology 83:1, pages 71-79.
Crossref

Chan Zhang, Xiaochun Jiang, Wanlu Chen, Qi Li, Fubin Yun, Xin Yang, Run Dai & Yujing Cheng. (2018) Population genetic difference of pharmacogenomic VIP gene variants in the Lisu population from Yunnan Province. Medicine 97:52, pages e13674.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

The effect of CYP2D6 10* polymorphism on adjuvant tamoxifen in Asian breast cancer patients: a meta-analysis

Articles from other publishers (17)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

The effect of CYP2D6 *10 polymorphism on adjuvant tamoxifen in Asian breast cancer patients: a meta-analysis

Citations (17)

Articles from other publishers (17)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

The effect of CYP2D6 10* polymorphism on adjuvant tamoxifen in Asian breast cancer patients: a meta-analysis